The outspread of Covid-19 also called as the novel Coronavirus started in 2019 in Wuhan, Hubei Province in China. From China it spread to the whole world at a very rapid rate. The common symptoms of this virus which is similar to SARS-CoV are infections in respiratory tract, acute respiratory distress syndrome, restlessness, body pain, loss of taste and smell, conjunctivitis and also pneumonia in severe cases which may or may not be life threatening. Since it affects in all age groups, pregnant women are also susceptible to this virus. However, in pregnant women with COVID-19 there is no evidence for vertical transmission but surely there is an increased risk of preterm deliveries by altering the immune response of the mother and the baby both as pregnant women are generally at risk of respiratory infections. Status of Covid-19 in Pregnant Women We concluded that pregnancy and child birth do not increase the pace of symptoms of this disease inside the body. It also does not aggravate the course of COVID-19 pneumonia. Even the women who do not get antiviral drugs treatment stay well off after child birth is over and achieve good recovery from COVID-19 pneumonia. Although negligence should be avoided while handling these type of cases as it might be life threatening.

The medical device market is generally seen as an area with high growth potential and provides greater profit margins including significant positive benefits to the patients. As the medical device regulations and the guidance document are becoming stringent in the US, manufacturers of these types of products are now facing these conundrums along with a need for clarification on matters related to various drug and device provisions. The European Union is making major changes to the Medical Device Directive which is its regulatory scheme for devices. Some parts are focused on the medical devices. The new changes in the regulations represent an important step forward in the growing philosophy of medical devices in Europe. Along with the regulatory challenges, there are various challenges faced during the innovation of such products. There are many factors that affect innovation including the patent aspects. In general, the key thing is that small firm face lots of difficulty compared to larger firm in bringing medical device in market. Thus, the proposed manuscript focuses on understanding the regulatory issues in various countries for ease of innovation and marketing authorization of medical devices.

No abstract

No abstract

No abstract